• All sections
  • C - Chemistrymetallurgy
  • C07C - Acyclic or carbocyclic compounds
  • C07C 311/19 - Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Patent holdings for IPC class C07C 311/19

Total number of patents in this class: 142

10-year publication summary

11
9
13
9
9
10
7
6
7
2
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
The Governing Council of The University of Toronto,
1541
6
Molecular Insight Pharmaceuticals, Inc.
56
6
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
824
5
Navitor Pharmaceuticals, Inc.
35
5
The University of Melbourne
556
4
University of Alcala de Henares
5
4
Cornell University
3396
3
H. Lee Moffitt Cancer Center and Research Institute, Inc.
1008
3
Ligand Pharmaceuticals Incorporated
169
3
South Rampart Pharma, LLC
3
3
Centessa Pharmaceuticals (UK) Limited
59
3
MAM - Age S.r.l.
3
3
Novartis AG
10341
2
Boehringer Ingelheim International GmbH
4496
2
Duke University
3170
2
University of South Florida
1872
2
Northwestern University
3521
2
AMOREPACIFIC Corporation
2890
2
The Brigham and Women's Hospital, Inc.
2272
2
Epizyme, Inc.
357
2
Other owners 78